Literature DB >> 17663419

Teratology public affairs committee position paper: Pregnancy labeling for prescription drugs: Ten years later.

.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17663419     DOI: 10.1002/bdra.20389

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


× No keyword cloud information.
  8 in total

1.  Assessment of foetal risk associated with 93 non-US-FDA approved medications during pregnancy.

Authors:  Ahmed H Al-Jedai; Sakra S Balhareth; Roaa A Algain
Journal:  Saudi Pharm J       Date:  2012-05-19       Impact factor: 4.330

2.  FDA pregnancy risk categories and the CPS: do they help or are they a hindrance?

Authors:  Ruth Law; Pina Bozzo; Gideon Koren; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2010-03       Impact factor: 3.275

3.  Providing contraception for women taking potentially teratogenic medications: a survey of internal medicine physicians' knowledge, attitudes and barriers.

Authors:  David L Eisenberg; Catherine Stika; Ami Desai; David Baker; Kathleen J Yost
Journal:  J Gen Intern Med       Date:  2010-01-20       Impact factor: 5.128

4.  Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov.

Authors:  Chris Stockmann; Catherine M T Sherwin; Gideon Koren; Sarah C Campbell; Jonathan E Constance; Matthew Linakis; Alfred Balch; Michael W Varner; Michael G Spigarelli
Journal:  J Clin Pharmacol       Date:  2013-11-14       Impact factor: 3.126

Review 5.  The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history.

Authors:  Norman R Saunders; Jean-Jacques Dreifuss; Katarzyna M Dziegielewska; Pia A Johansson; Mark D Habgood; Kjeld Møllgård; Hans-Christian Bauer
Journal:  Front Neurosci       Date:  2014-12-16       Impact factor: 4.677

Review 6.  A review of diagnosis and treatment of acne in adult female patients.

Authors:  A U Tan; B J Schlosser; A S Paller
Journal:  Int J Womens Dermatol       Date:  2017-12-23

7.  Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems.

Authors:  Pierre-Olivier Blotière; Christine Damase-Michel; Alain Weill; Géric Maura
Journal:  Drug Saf       Date:  2021-10-06       Impact factor: 5.606

8.  Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule.

Authors:  John J Byrne; Alexander M Saucedo; Catherine Y Spong
Journal:  JAMA Netw Open       Date:  2020-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.